The rat Pig-a assay using an erythroid HIS49 antibody in a single dose study of isopropyl p-toluenesulfonate

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 811, Issue , 2016, Pages 110-116

  Chikura, Satsuki ^a   Okada, Yuki ^a   Kimoto, Takafumi ^a   Kaneko, Hideshi ^a   Miura, Daishiro ^a   Kasahara, Yoshinori ^a  

^a TEIJIN PHARMA LIMITED   (Japan)

Author keywords

Flow cytometry; Gene mutation; IPTS; Pig a assay

Indexed keywords

CD71 ANTIGEN; HIS49 PROTEIN; ISOPROPYL P TOLUENESULFONATE; PROTEIN; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 4-TOLUENESULFONIC ACID; ANTIBODY; BENZENESULFONIC ACID DERIVATIVE; MEMBRANE PROTEIN; MUTAGENIC AGENT; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BLOOD SAMPLING; BODY WEIGHT; BONE MARROW TOXICITY; CONTROLLED STUDY; ERYTHROCYTE; GENE FREQUENCY; IN VIVO STUDY; MALE; MAXIMUM TOLERATED DOSE; MUTAGENICITY; MUTANT FREQUENCY; NONHUMAN; PIG; PIG A ASSAY; PIGRET ASSAY; PRIORITY JOURNAL; RAT; RETICULOCYTE; ANIMAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MUTAGEN TESTING; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES; BENZENESULFONATES; BODY WEIGHT; ERYTHROCYTES; MALE; MEMBRANE PROTEINS; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84969505780     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2016.04.005     Document Type: Article

References (24)

1. [1] Gollapudi, B.B., Lynch, A.M., Heflich, R.H., Dertinger, S.D., Dobrovolsky, V.N., Froetschl, R., Horibata, K., Kenyon, M.O., Kimoto, T., Lovell, D.P., Stankowski, L.F. Jr., White, P.A., Witt, K.L., Tanir, J.Y., The in vivo pig-a assay: a report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup. Mutat. Res. 783 (2015), 23–35.
2. [2] Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk, ICH-M7, (2014).
3. [3] Araten, D.J., Nafa, K., Pakdeesuwan, K., Luzzatto, L., Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 5209–5214.
4. [4] Miura, D., The in vivo Pig-a gene mutation assay. Genes Environ. 36 (2014), 169–173.
5. [5] Dobrovolsky, V.N., Miura, D., Heflich, R.H., Dertinger, S.D., The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ. Mol. Mutagen. 51 (2010), 825–835.
6. [6] Heflich, R.H., Dobrovolsky, V.N., Dertinger, S.D., Continued progress in developing the Pig-a gene mutation assay. Mutagenesis 30 (2015), 313–314.
7. [7] Miura, D., Dobrovolsky, V.N., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ. Mol. Mutagen. 49 (2008), 614–621.
8. [8] Bryce, S.M., Bemis, J.C., Dertinger, S.D., In vivo mutation assay based on the endogenous Pig-a locus. Environ. Mol. Mutagen. 49 (2008), 256–264.
9. [9] Dertinger, S.D., Bryce, S.M., Phonethepswath, S., Avlasevich, S.L., When Pigs Fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis. Mutat. Res. 721 (2011), 163–170.
10. [10] Dertinger, S.D., Phonethepswath, S., Weller, P., Avlasevich, S., Torous, D.K., Mereness, J.A., Bryce, S.M., Bemis, J.C., Bell, S., Portugal, S., Aylott, M., MacGregor, J.T., Interlaboratory Pig-a gene mutation assay trial: studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes. Environ. Mol. Mutagen. 52 (2011), 748–755.
11. [11] Dertinger, S.D., Phonethepswath, S., Weller, P., Nicolette, J., Murray, J., Sonders, P., Vohr, H.W., Shi, J., Krsmanovic, L., Gleason, C., Custer, L., Henwood, A., Sweder, K., Stankowski, L.F. Jr., Roberts, D.J., Giddings, A., Kenny, J., Lynch, A.M., Defrain, C., Nesslany, F., van der Leede, B.J.M., Van Doninck, T., Schuermans, A., Tanaka, K., Hiwata, Y., Tajima, O., Wilde, E., Elhajouji, A., Gunther, W.C., Thiffeault, C.J., Shutsky, T.J., Fiedler, R.D., Kimoto, T., Bhalli, J.A., Heflich, R.H., MacGregor, J.T., International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories. Environ. Mol. Mutagen. 52 (2011), 690–698.
12. [12] Dobrovolsky, V.N., Boctor, S.Y., Twaddle, N.C., Doerge, D.R., Bishop, M.E., Manjanatha, M.G., Kimoto, T., Miura, D., Heflich, R.H., Ferguson, S.A., Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-Specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Environ. Mol. Mutagen. 51 (2010), 138–145.
13. [13] Kimoto, T., Horibata, K., Chikura, S., Hashimoto, K., Itoh, S., Sanada, H., Muto, S., Uno, Y., Yamada, M., Honma, M., Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat. Res. 755 (2013), 126–134.
14. [14] Kimoto, T., Chikura, S., Suzuki, K., Kobayashi, X.M., Itano, Y., Horibata, K., Honma, M., Dobrovolsky, V.N., Heflich, R.H., Miura, D., Kasahara, Y., Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ. Mol. Mutagen. 52 (2011), 774–783.
15. [15] Horibata, K., Ukai, A., Honma, M., Evaluation of rats’ in vivo genotoxicity induced by N-ethyl-N-nitrosourea in the RBC Pig-a, PIGRET, and gpt assays. Genes Environ. 36 (2014), 199–202.
16. [16] Itoh, S., Nagata, M., Hattori, C., Takasaki, W., In vivo mutagenicity of ethyl methanesulfonate detected by Pig-a and PIGRET assays. Genes Environ. 36 (2014), 174–178.
17. [17] Kimoto, T., Chikura, S., Suzuki-Okada, K., Kobayashi, X., Itano, Y., Miura, D., Kasahara, Y., The rat pig-a mutation assay in single and 28 day-repeated dose study of cyclophosphamide: the PIGRET assay can detect the in vivo mutagenicity earlier than the RBC pig-a assay. Genes Environ. 36 (2014), 191–198.
18. [18] Muto, S., Yamada, K., Kato, T., Iwase, Y., Uno, Y., Pig-a gene mutation and micronucleus induction in rat peripheral blood by methyl methanesulfonate. Genes Environ. 36 (2014), 186–190.
19. [19] Sanada, H., Okamoto, M., Ohsumi, T., Nakamura, T., Evaluation for a mutagenicity of 4,4'-methylenedianiline on hematopoietic cells by a Pig-a gene mutation assay in rats. Genes Environ. 36 (2014), 179–185.
20. [20] Glowienke, S., Frieauff, W., Allmendinger, T., Martus, H.J., Suter, W., Mueller, L., Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters. Mutat. Res. 581 (2005), 23–34.
21. [21] Sobol, Z., Engel, M.E., Rubitski, E., Ku, W.W., Aubrecht, J., Schiestl, R.H., Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Mutat. Res. 633 (2007), 80–94.
22. [22] Kimoto, T., et al. The PIGRET assay, a method for measuring Pig-a gene mutation in reticulocytes, is reliable as a short-term in vivo genotoxicity test: summary of the MMS/JEMS-collaborative study across 16 laboratoriesusing 24 chemicals. Mutat. Res. 811 (2016), 3–15.
23. [23] Dobrovolsky, V.N., Revollo, J., Pearce, M.G., Pacheco-Martinez, M.M., Lin, H., CD48-deficient T-lymphocytes from DMBA-treated rats have de novo mutations in the endogenous Pig-a gene. Environ. Mol. Mutagen. 56 (2015), 674–683.
24. [24] Miura, D., Dobrovolsky, V.N., Mittelstaedt, R.A., Kasahara, Y., Katsuura, Y., Heflich, R.H., Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-Cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ. Mol. Mutagen. 49 (2008), 622–630.